Genpharmasec Limited (BOM:531592)
India
· Delayed Price · Currency is INR 2.120
+0.010 (0.47%)
At close: Jun 9, 2025
Genpharmasec Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| Net Income | 12.31 | -1.26 | 11.25 | -2.09 | 12.57 | Upgrade
|
| Depreciation & Amortization | 8.12 | 0.42 | 0.2 | 0.14 | 0.13 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | 0.09 | - | Upgrade
|
| Provision & Write-off of Bad Debts | 3.94 | 4.27 | 1.75 | - | - | Upgrade
|
| Other Operating Activities | -16.69 | 2.52 | -6.1 | -3.3 | -4.26 | Upgrade
|
| Change in Accounts Receivable | -48.9 | -33.91 | 7.39 | 10.77 | -4.92 | Upgrade
|
| Change in Inventory | 6.45 | 8.33 | 2.13 | -22.08 | -42.21 | Upgrade
|
| Change in Accounts Payable | 58.8 | 10.09 | -48.51 | -8.95 | 15.74 | Upgrade
|
| Change in Other Net Operating Assets | 5.93 | -19.92 | 1.29 | 1.98 | 1.6 | Upgrade
|
| Operating Cash Flow | 29.96 | -29.46 | -30.6 | -23.44 | -21.35 | Upgrade
|
| Capital Expenditures | -57.05 | -0.18 | -0.16 | -0.81 | -0.13 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | 0.02 | - | Upgrade
|
| Investment in Securities | - | -176.4 | 3.33 | 2.73 | -62.32 | Upgrade
|
| Other Investing Activities | 22.83 | 4.73 | 0.23 | 0.66 | 3.27 | Upgrade
|
| Investing Cash Flow | -153.07 | -280.63 | 3.63 | 4.18 | -14.1 | Upgrade
|
| Long-Term Debt Issued | - | 54.8 | 30.4 | - | - | Upgrade
|
| Long-Term Debt Repaid | -6.23 | -57.64 | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | -6.23 | -2.84 | 30.4 | - | - | Upgrade
|
| Issuance of Common Stock | - | 484.51 | - | - | 45 | Upgrade
|
| Other Financing Activities | -6.26 | -3.2 | 0.42 | - | - | Upgrade
|
| Financing Cash Flow | -12.49 | 478.47 | 30.82 | - | 45 | Upgrade
|
| Net Cash Flow | -135.6 | 168.38 | 3.85 | -19.26 | 9.55 | Upgrade
|
| Free Cash Flow | -27.1 | -29.64 | -30.76 | -24.25 | -21.47 | Upgrade
|
| Free Cash Flow Margin | -8.04% | -9.75% | -12.05% | -8.88% | -10.08% | Upgrade
|
| Free Cash Flow Per Share | - | -0.10 | -0.11 | -0.09 | -0.08 | Upgrade
|
| Cash Interest Paid | 6.26 | - | - | - | - | Upgrade
|
| Cash Income Tax Paid | 0.74 | 0.41 | -2.55 | 0.3 | 3.51 | Upgrade
|
| Levered Free Cash Flow | -27.04 | -29.15 | -43.65 | -44.21 | 7.35 | Upgrade
|
| Unlevered Free Cash Flow | -24.32 | -26.59 | -43.3 | -44.21 | 7.35 | Upgrade
|
| Change in Net Working Capital | -29.29 | 26.85 | 44.89 | 40.2 | 0.03 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.